EL
ALT icon

EMFO LLC’s Altimmune ALT Stock Holding History

EMFO LLC’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,000
Closed -$53.1K – 340
2021
Q3 		$57K Hold
5,000
– – 0.05% 195
2021
Q2 		$49K Buy
+5,000
New +$68.4K 0.04% 205

Other funds holding ALT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

EMFO LLC's ALT Position: Q4 2021 in Review

EMFO LLC sold out of Altimmune (ALT) in Q4 2021, closing a stake of 5,000 shares — an estimated $53.1K sold.

EMFO LLC first reported a position in ALT in Q2 2021 and held it in 2 quarters. The position peaked at $57K in Q3 2021. 102 funds tracked by Wall St. Rank hold ALT as of Q4 2021.

  • EMFO LLC reported no remaining Altimmune position as of Q4 2021 after selling out during the quarter.
  • EMFO LLC sold 5,000 Altimmune shares in Q4 2021, an estimated $53.1K.
  • EMFO LLC first reported a position in Altimmune in Q2 2021 and held it in 2 quarters.
  • EMFO LLC's Altimmune position peaked at $57K in Q3 2021.
  • 102 funds tracked by Wall St. Rank held Altimmune as of Q4 2021.

Based on EMFO LLC's 13F filing for Q4 2021, filed 27 Jan 2022.